The Analyte Behind a Positive Whole-Blood Cannabinoid Screen

A positive whole-blood cannabinoid screen in this inhalation study was not a direct quantitative measurement of parent THC. The ELISA used a THCCOOH-based cutoff and responded to more than one cannabinoid.

The screen and the quantitative assay measured differently

In seventeen adults who had not used cannabis in the preceding month, researchers collected whole blood after smoked and vaporized cannabis. The blood ELISA used a cutoff of 10 ng/mL for THCCOOH, a THC metabolite.

The paper separately reported manufacturer-described cross-reactivity, including response to parent THC. The accompanying liquid chromatography–tandem mass spectrometry analysis quantified THC, 11-OH-THC, THCCOOH and THCCOOH-glucuronide individually. A screening classification and those compound-specific concentrations were different outputs.

The cutoff label matters

Calling the screening cutoff “10 ng/mL THC” would change the analyte named by the method. Nor can a positive screen be converted directly into an exact concentration of parent THC when several compounds can contribute to its response.

Interpretation should retain the specimen matrix, target calibrator, cross-reactivity information and confirmation procedure. An oral-fluid or urine screen may have a different target and different analytical characteristics even when all are described informally as cannabis tests.

Detection and impairment remain separate

The study’s concentrations did not yield a single reliable indicator of behavioral impairment. The pharmacokinetic paper and its companion acute-effects report also describe the same participant experiment, not independent replications. The useful first question is what the positive screen actually represents before drawing conclusions about functioning.

Related analysis: blood and oral-fluid patterns after inhaled cannabis.

Research cited

Spindle and colleagues (2019), Acute Pharmacokinetic Profile of Smoked and Vaporized Cannabis in Human Blood and Oral Fluid. DOI: 10.1093/jat/bky104.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

The HGN Comparison Did Not Validate a Standalone Cannabis Impairment Test

The HGN analysis compared small groups defined by self-reported duration. It did not establish a standalone diagnostic accuracy for identifying cannabis-impaired drivers. What the statistical comparison involved Forty-four participants underwent horizontal gaze nystagmus assessment, with forty-three examined at three hours after smoking. The paper compared HGN incidence at that time…

Spread the love

Read Article: The HGN Comparison Did Not Validate a Standalone Cannabis Impairment Test

Stratified Cannabis Duration Patterns Coexisted With a Null Overall Correlation

The paper described an inverse pattern after grouping participants by self-reported duration, while its unstratified correlation between baseline blood THC and duration was nonsignificant. Both findings belong in an accurate account. The two analyses asked related questions differently Baseline blood measurements were available for sixty-four participants. The authors divided participants…

Spread the love

Read Article: Stratified Cannabis Duration Patterns Coexisted With a Null Overall Correlation

Percent-of-Maximum Cannabis Ratings Did Not Compare Absolute Severity

The paper’s average percent-of-maximum curve normalized each participant to that person’s own highest self-rating. Equal percentages on that graph did not necessarily mean equal absolute symptom severity across participants. The denominator was personal Wurz and DeGregorio summarized self-assessments from seventy-four participants after cannabis smoking. Each person’s ratings were expressed relative…

Spread the love

Read Article: Percent-of-Maximum Cannabis Ratings Did Not Compare Absolute Severity

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us